Back to Search
Start Over
Safe use of hydroxycarbamide in sickle cell disease patients hospitalized for painful vaso‐occlusive episodes during the randomized, open‐label HELPS study.
- Source :
- British Journal of Haematology; Oct2022, Vol. 199 Issue 1, p153-157, 5p
- Publication Year :
- 2022
-
Abstract
- Four and three patients in each group (respectively) were on continuous HC therapy upon inclusion, and one patient in the non-intervention arm continued taking HC (20 mg/kg/day) throughout the study (the other patients in this group did not take their medication to the ER). Safe use of hydroxycarbamide in sickle cell disease patients hospitalized for painful vaso-occlusive episodes during the randomized, open-label HELPS study. [Extracted from the article]
- Subjects :
- SICKLE cell anemia
LEUKOCYTE count
Subjects
Details
- Language :
- English
- ISSN :
- 00071048
- Volume :
- 199
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- British Journal of Haematology
- Publication Type :
- Academic Journal
- Accession number :
- 159326135
- Full Text :
- https://doi.org/10.1111/bjh.18349